FDA finds asbestos in three Claire’s cosmetics products

Mar 6, 2019

By Chad Terhune (Reuters) – The U.S. Food and Drug Administration called on Congress to...

U.S. bolsters ‘Beagle Brigade’ to sniff out deadly hog virus

Mar 6, 2019

By Tom Polansek CHICAGO (Reuters) – The U.S. government will employ more dogs to sniff out...

Aerobic exercise eases depression, even in chronically ill

Mar 6, 2019

By Lisa Rapaport (Reuters Health) – People with chronic health problems who suffer from...

Allergan depression treatment fails studies, shares slip

Mar 6, 2019

By Manojna Maddipatla (Reuters) – Allergan Plc said on Wednesday its experimental add-on...

Sinus problems tied to higher risk of depression, anxiety

Mar 6, 2019

By Lisa Rapaport (Reuters Health) – People who suffer from a common chronic sinus disorder...

Patients not harmed when trainee doctors work 28-hour shifts

Mar 6, 2019

By Gene Emery (Reuters Health) – Hospital residents working 80 hours a week get nearly as much sleep and provide comparable patient care whether their schedule is highly-structured or more flexible, according to a study...

J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades

Mar 6, 2019

By Saumya Joseph (Reuters) – The U.S. Food and Drug Administration on Tuesday said it...

Women who vape around pregnancy may wrongly think it safe

Mar 6, 2019

By Carolyn Crist (Reuters Health) – Health professionals advise against using any nicotine products during pregnancy, but some women are using e-cigarettes before, during or after pregnancy and thinking it’s safer...

Inducing labor at 41 weeks slightly safer than waiting longer

Mar 6, 2019

By Lisa Rapaport (Reuters Health) – When pregnant women have not delivered by around 41 weeks, their babies are slightly less likely to have serious complications if labor is induced instead of letting nature take its...

J&J prices ketamine-like depression treatment at $590-$885 for two doses

Mar 6, 2019

(Reuters) – Johnson & Johnson said on Wednesday its nasal spray depression treatment,...

Vertex cystic fibrosis triple combo therapy succeeds in important trials

Mar 6, 2019

By Manas Mishra (Reuters) – Vertex Pharmaceuticals Inc on Wednesday said its...

Canada advisory group calls for new prescription drug agency

Mar 6, 2019

By Allison Martell TORONTO (Reuters) – A Canadian advisory council studying prescription drug coverage said on Wednesday the federal government should create an arm’s-length national drug agency to manage and oversee...

Side effects of Alnylam’s gene-silencing drug raise concerns, shares slip

Mar 6, 2019

By Saumya Joseph (Reuters) – Alnylam Pharmaceuticals Inc’s late-stage trial data on its new gene silencing drug cast doubt on its safety, even as results revealed its effectiveness in treating a rare, painful...

World’s second man cleared of AIDS virus invigorates quest for cure

Mar 6, 2019

By Kate Kelland and Julie Steenhuysen LONDON/CHICAGO (Reuters) – Scientific investigation...

MSF-run hospital develops 3D printed prosthetics for war victims

Mar 6, 2019

AMMAN (Reuters) – A hospital in Jordan has given a victim of Yemen’s war new hope for...

Bayer launches combination insecticide to fight resistance malaria

Mar 6, 2019

JOHANNESBURG (Reuters) – German drugmaker Bayer AG launched on Wednesday the world’s...

National Colorectal Cancer Awareness Month: Prevention, Diagnosis and Treatment (Part 1)

Mar 6, 2019

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Paul Berggreen and Dr. Daniel Jondle, both from Arizona Digestive Health, in Phoenix, Arizona, about Colorectal Cancer.

Today’s program is the first of a 3-part series about the…